Diseases that dominate the 21st century need a 21st century approach in the way we design and conduct clinical trials. To meet this need, George Clinical is primarily focused on large-scale studies with high-impact outcomes, particularly where smaller pre-registration trials need to be expanded to larger populations.
Having confidence that proven treatments will work in 'the real world' is a high priority for healthcare organisations, especially in low and middle-income countries where there is a large burden of chronic disease.
